Small incisions

Article

Breaking news from the floor of ESCRS

Rayner Intraocular Lenses has been displaying the RaySert, a small incision IOL injector system. With a 1.8 mm diameter external tip, the system is reported to enable surgeons to insert an IOL through a sub 2.5 mm incision, which leads to enhanced patient comfort and recovery.

Adrian Webber, director of sales and marketing at Rayner, explained the appeal of going smaller: “There are big moves among ophthalmic surgeons to implant lenses through smaller incision sizes to fit with their phaco procedures; it reduces the chances of surgically induced astigmatism.” He said that the company is finding that “the smaller the incision the more preferable it is for many surgeons these days.”

“IOL injections through small incisions need not compromise on lens design,” said Ashok Vyas, MD, who has experienced the system first hand.

Designed for use initially with the company’s C-flex range of IOLs, the system assures ease of use with controlled delivery through a single-handed injection system.

“The RaySert is the same overall design as our regular lens injectors,” said Webber. “It is the same loading procedures so that surgeons who are used to our regular lens injector will find with RaySert it is exactly the same except it is now with a smaller incision size.”

“As an innovator in IOL technology, the introduction of the RaySert small incision injector system is a natural progression in delivering physicians with a new level of control and ease in IOL delivery,” says Donald J. Munro, the company’s chairman and managing director.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.